Screening and isolation for anti-hepatofibrotic components from medicinal mushrooms using TGF-β1-induced live fibrosis in hepatic stellate cells

International Journal of Medicinal Mushrooms

Volumn 16, Issue 6, 2014, Pages 529-539

  Geng, Yan ^a   Wang, Jing ^a   Xie, Minfeng ^a   Lu, Zhen Ming ^a   Xu, Hong Yu ^a   Shi, Jin Song ^a   Xu, Zheng Hong ^a,b  

^a JIANGNAN UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

Anti fibrotic activity; Antrodia camphorate; Cell model; Liver fibrosis; Medicinal mushrooms; Picro sirius red staining; TGF 1

Indexed keywords

2 (2 ETHOXY 4 FORMYLPHENOXY) 4 (2 METHOXYPHENYL)ACETAMIDE; 2 [(4,6,7 TRIMETHYLQUINAZOLIN 2 YL)AMINO]QUINAZOLIN 4 OL; 3 [[1 [(5 HYDROXYPENTYL)AMINO] 4 METHYL 1 OXO 2 PENTANYL]CARBAMOYL] 2 OXIRANECARBOXYLICACID; 4 PIPERIDINE CARBOXAMIDE,1 [2 (8 QUINOLINYLOXY)ACETYL]; 8 METHYL 7 [(2 OXOCYCLOHEXYL)OXY] 4 PROPYL 2H CHROMEN 2 ONE; ALPHA SMOOTH MUSCLE ACTIN; ANTRODIA CAMPHORATA EXTRACT; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DIMETHYL(6S) 4 O ACETYL 5 AZIDO 3,5 DIDEOXY 6 [(2S) 2,3 DIACETOXYPROPYL] ALPHA THREO HEX 2 ULOPYRANOSIDONAT; FIBRONECTIN; FUNGAL EXTRACT; MESSENGER RNA; METHYL 4-[(4 (ETHYLAMINO) 6 (ISOPROPYLAMINO) 1,3,5 TRIAZIN 2 YL)OXY] BENZOATE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT;

ANTI HEPATOFIBROTIC ACTIVITY; ANTRODIA CAMPHORATA; ARMILLARIA MELLEA; ARTICLE; BIOLOGICAL ACTIVITY; CELL VIABILITY; CEPHALOSPORIUM; CONTROLLED STUDY; CORDYCEPS; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; GANODERMA LUCIDUM; HERICIUM ERINACEUS; HUMAN; HUMAN CELL; LIVER FIBROSIS; MEDICINAL MUSHROOM; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STELLATE CELL; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WESTERN BLOTTING; AGARICALES; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMICALLY INDUCED; CHEMISTRY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECTS; FIBROSIS; ISOLATION AND PURIFICATION;

AGARICALES; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FIBROSIS; HEPATIC STELLATE CELLS; MOLECULAR STRUCTURE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84907995426     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushrooms.v16.i6.30     Document Type: Article

References (30)

1. Friedman SL. Liver fibrosis—from bench to bedside. J Hepatology. 2003;38 Suppl 1:S38-53.
2. Bataller R, Brenner DA. Liver fibrosis. J Clin Investigation. 2005;115(2):209-18.
3. Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest. 2013;123(5):1887-901.
4. Gabele E, Brenner DA, Rippe RA. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci. 2003;8:d69-77.
5. Yin C, Evason KJ, Asahina K, Stainier DY. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest. 2013;123(5):1902-10.
6. Blaner WS, O’Byrne SM, Wongsiriroj N, Kluwe J, D’Ambrosio DM, Jiang H, Schwabe RF, Hillman EM, Piantedosi R, Libien J. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta. 2009;1791(6):467-73.
7. Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol. 2000;35(9):665-72.
8. Roskams T. Relationships among stellate cell activation, progenitor cells, and hepatic regeneration. Clin Liver Dis. 2008;12(4):853-60, ix.
9. Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25(2):195-206.
10. Ying J, Xu Y, Wang Y. Icons of medicinal fungi from China (translation Xu YH). Beijing: Science Press, 1987.
11. Geng Y, Lu ZM, Huang W, Xu HY, Shi JS, Xu ZH. Bioassay-guided isolation of DPP-4 inhibitory fractions from extracts of submerged cultured of Inonotus obliquus. Molecules. 2013;18(1):1150-61.
12. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolver problems. Int J Med Mushrooms. 2010;12(1):1-16.
13. Chang S-T, Wasser SP. The role of culinary-medicinal mushrooms on human welfare with pyramid model for human health. Int J Med Mushrooms. 2012; 14 (2):95-134.
14. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci. 2002;7:d793-807.
15. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterol. 2008;134(6):1655-69.
16. Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 2007;56(2):284-92.
17. Meindl-Beinker NM, Dooley S. Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis. J Gastroenterol Hepatol. 2008;23 Suppl 1:S122-27.
18. Greenwel P, Schwartz M, Rosas M, Peyrol S, Grimaud JA, Rojkind M. Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. Lab Invest. 1991;65(6):644-53.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunologcal Methods. 1983;65(1-2):55-63.
20. Sweat F, Puchtler H, Rosenthal SI. Sirius red F3BA as a stain for connective tissue. Arch Pathol. 1964;78:69-72.
21. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA. 2004;101(41):14895-900.
22. Cheng K, Yang N, Mahato RI. TGF-beta1 gene silencing for treating liver fibrosis. Mol Pharm. 2009;6(3):772-79.
23. Heinemeier KM, Olesen JL, Haddad F, Langberg H, Kjaer M, Baldwin KM, Schjerling P. Expression of collagen and related growth factors in rat tendon and skeletal muscle in response to specific contraction types. J Physiol. 2007 Aug 1;582:1303-16.
24. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 Is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002 July 1, 2002;62(1):65-74.
25. Eickelberg O. Endless healing: TGF-beta, SMADs, and fibrosis. FEBS Lett. 2001;506(1):11-14.
26. Geethangili M, Tzeng YM. Review of pharmacological effects of antrodia camphorata and its bioactive compounds. Evid Based Complement Alternat Med. 2011; 212641.
27. Fazenda ML, Seviour R, McNeil B, Harvey LM. Submerged culture fermentation of “higher fungi”: the macrofungi. Adv Appl Microbiol. 2008;63:33-103.
28. Geng Y, He Z, Lu ZM, Xu HY, Xu GH, Shi JS, Xu ZH. Antrodia camphorata ATCC 200183 sporulates asexually in submerged culture. Appl Microbiol Biotechnol. 2013;97(7):2851-58.
29. Lin WC, Kuo SC, Lin WL, Fang HL, Wang BC. Filtrate of fermented mycelia from Antrodia camphorata reduces liver fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol. 2006;12(15):2369-74.
30. Wang LC, Kuo IU, Tsai TY, Lee CL. Antrodia camphorata-fermented product cultured in deep ocean water has more liver protection against thioacetamide-induced fibrosis. Appl Microbiol Biotechnol. 2013;97(23):9955-67.